Literature DB >> 9311741

Localization of a gene for autosomal dominant osteopetrosis (Albers-Schönberg disease) to chromosome 1p21.

W Van Hul1, J Bollerslev, J Gram, E Van Hul, W Wuyts, O Benichou, F Vanhoenacker, P J Willems.   

Abstract

Albers-Schönberg disease, the classical form of osteopetrosis, is an autosomal dominant condition with generalized increased skeletal density due to reduced bone resorption. Characteristic radiological findings are generalized osteosclerosis, with, most typically, end-plate sandwichlike thickening of the vertebrae (Rugger-Jersey spine) and the bone-within-bone (endobones) phenomenon. We studied an extended kindred with Albers-Schönberg disease and found linkage with several markers from chromosome 1p21. The Albers-Schönberg gene is located in a candidate region of approximately 8.5 cM flanked by markers D1S486 and D1S2792. A maximum LOD score (Z(max)) of 4.09 was obtained in multipoint analysis at loci D1S239/D1S248. Possible linkage of osteopetrosis to this chromosomal region was analyzed because the CSF-1 gene, which is mutated in the op/op mouse model for osteopetrosis, is located in 1p21. However, SSCP and mutation analysis in patients did not reveal any abnormality, which excludes the CSF-1 gene as the disease-causing gene. This was confirmed by refined physical mapping of the CSF-1 gene outside the candidate region for the Albers-Schönberg gene. The identification of the molecular defect underlying Albers-Schönberg disease will therefore be dependent on the isolation of other genes from an 8.5-cM candidate region on chromosome 1p21.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9311741      PMCID: PMC1715917          DOI: 10.1086/514844

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  39 in total

1.  Osteopetrosis in children: a report of 26 cases.

Authors:  R Loría-Cortés; E Quesada-Calvo; C Cordero-Chaverri
Journal:  J Pediatr       Date:  1977-07       Impact factor: 4.406

2.  Pathogenesis of osteopetrosis in the ia rat: reduced bone resorption due to reduced osteoclast function.

Authors:  S C Marks
Journal:  Am J Anat       Date:  1973-10

3.  Easy calculations of lod scores and genetic risks on small computers.

Authors:  G M Lathrop; J M Lalouel
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

4.  Failure of bone resorption in a calf.

Authors:  R G Thomson
Journal:  Pathol Vet       Date:  1966

5.  Osteopetrosis, a new recessive skeletal mutation on chromosome 12 of the mouse.

Authors:  S C Marks; P W Lane
Journal:  J Hered       Date:  1976 Jan-Feb       Impact factor: 2.645

6.  A mild autosomal recessive form of osteopetrosis.

Authors:  S G Kahler; J A Burns; A S Aylsworth
Journal:  Am J Med Genet       Date:  1984-02

Review 7.  A review of the osteopetroses.

Authors:  P Beighton; F Horan; H Hamersma
Journal:  Postgrad Med J       Date:  1977-08       Impact factor: 2.401

8.  Osteopetrosis: further heterogeneity.

Authors:  W A Horton; R N Schimke; T Iyama
Journal:  J Pediatr       Date:  1980-10       Impact factor: 4.406

9.  Osteopetrosis, renal tubular acidosis and basal ganglia calcification in three sisters.

Authors:  M P Whyte; W A Murphy; M D Fallon; W S Sly; S L Teitelbaum; W H McAlister; L V Avioli
Journal:  Am J Med       Date:  1980-07       Impact factor: 4.965

10.  Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis.

Authors:  A R Hayman; S J Jones; A Boyde; D Foster; W H Colledge; M B Carlton; M J Evans; T M Cox
Journal:  Development       Date:  1996-10       Impact factor: 6.868

View more
  14 in total

1.  Increased urine heparan and chondroitin sulphate excretion in patients with osteopetrosis.

Authors:  R D Steiner; M P Whyte; E Chang; J Hanks; C Mattes; H Senephansiri; K M Gibson
Journal:  J Inherit Metab Dis       Date:  2000-02       Impact factor: 4.982

2.  Van Buchem disease (hyperostosis corticalis generalisata) maps to chromosome 17q12-q21.

Authors:  W Van Hul; W Balemans; E Van Hul; F G Dikkers; H Obee; R J Stokroos; P Hildering; F Vanhoenacker; G Van Camp; P J Willems
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

3.  Localisation of the gene causing diaphyseal dysplasia Camurati-Engelmann to chromosome 19q13.

Authors:  K Janssens; R Gershoni-Baruch; E Van Hul; R Brik; N Guañabens; N Migone; L A Verbruggen; S H Ralston; M Bonduelle; L Van Maldergem; F Vanhoenacker; W Van Hul
Journal:  J Med Genet       Date:  2000-04       Impact factor: 6.318

4.  Mapping of autosomal dominant osteopetrosis type II (Albers-Schönberg disease) to chromosome 16p13.3.

Authors:  O Bénichou; E Cleiren; J Gram; J Bollerslev; M C de Vernejoul; W Van Hul
Journal:  Am J Hum Genet       Date:  2001-07-23       Impact factor: 11.025

5.  Camurati-Engelmann disease: imaging, clinical features and differential diagnosis.

Authors:  Aldona Bartuseviciene; Arturas Samuilis; Jovitas Skucas
Journal:  Skeletal Radiol       Date:  2009-02-12       Impact factor: 2.199

6.  Osteopetrosis of the mandible masquerading as tubercular osteomyelitis.

Authors:  Subramanya S Sharma; C Saravanan; V Sathyabama; C Satish
Journal:  BMJ Case Rep       Date:  2013-01-10

7.  [Case report: total hip replacement for osteopetrosis ossificans. Femoral neck nonunion].

Authors:  O Schoierer; R Hoffmann
Journal:  Unfallchirurg       Date:  2007-09       Impact factor: 1.000

Review 8.  Case reports: treatment of subtrochanteric and ipsilateral femoral neck fractures in an adult with osteopetrosis.

Authors:  Patrick Birmingham; Kathleen A McHale
Journal:  Clin Orthop Relat Res       Date:  2008-04-23       Impact factor: 4.176

9.  EXTL2, a member of the EXT family of tumor suppressors, controls glycosaminoglycan biosynthesis in a xylose kinase-dependent manner.

Authors:  Satomi Nadanaka; Shaobo Zhou; Shoji Kagiyama; Naoko Shoji; Kazuyuki Sugahara; Kazushi Sugihara; Masahide Asano; Hiroshi Kitagawa
Journal:  J Biol Chem       Date:  2013-02-10       Impact factor: 5.157

Review 10.  Allogeneic stem cell transplantation for the treatment of diseases associated with a deficiency in bone marrow products.

Authors:  Reuven Or; Memet Aker; Michael Yechiel Shapira; Igor Resnick; Menachem Bitan; Simcha Samuel; Shimon Slavin
Journal:  Springer Semin Immunopathol       Date:  2004-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.